UY35032A - Compuestos cristalinos - Google Patents

Compuestos cristalinos

Info

Publication number
UY35032A
UY35032A UY0001035032A UY35032A UY35032A UY 35032 A UY35032 A UY 35032A UY 0001035032 A UY0001035032 A UY 0001035032A UY 35032 A UY35032 A UY 35032A UY 35032 A UY35032 A UY 35032A
Authority
UY
Uruguay
Prior art keywords
crystal compounds
methylalaninamide
quinoxalin
ylidene
sulfamoyl
Prior art date
Application number
UY0001035032A
Other languages
English (en)
Inventor
Baillon Bruno
Baulier Virginie
Fugier Matthieu
Comte Myriam
Kozlovic Stephane
Marc-Antoine Perrin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY35032A publication Critical patent/UY35032A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan en este documento diversas formas polimorfas de N-(3-{[(2Z)-3-[(2-cloro-5-metoxifenil)amino]quinoxalin-2(1H)-ilideno]sulfamoil}fenil)-2-metilalaninamida.
UY0001035032A 2012-09-13 2013-09-13 Compuestos cristalinos UY35032A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261700618P 2012-09-13 2012-09-13
FR1356284 2013-06-28

Publications (1)

Publication Number Publication Date
UY35032A true UY35032A (es) 2014-04-30

Family

ID=50277664

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035032A UY35032A (es) 2012-09-13 2013-09-13 Compuestos cristalinos

Country Status (16)

Country Link
US (1) US9388143B2 (es)
EP (1) EP2895467A1 (es)
JP (1) JP2015528482A (es)
KR (1) KR20150056565A (es)
CN (1) CN104781241A (es)
AR (1) AR092501A1 (es)
AU (1) AU2013314292A1 (es)
BR (1) BR112015004901A2 (es)
CA (1) CA2884337A1 (es)
IL (1) IL237458A0 (es)
MX (1) MX2015003151A (es)
RU (1) RU2015113277A (es)
SG (1) SG11201501540VA (es)
TW (1) TW201422594A (es)
UY (1) UY35032A (es)
WO (1) WO2014041144A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3008620A1 (fr) * 2013-07-22 2015-01-23 Sanofi Sa Formulation de comprime d'un inhibiteur de phosphatidylinositol 3-kinase
CN104730028A (zh) * 2015-03-12 2015-06-24 浙江华峰氨纶股份有限公司 用于氨纶丝中溶剂残存含量的近红外光谱检测方法
DE102015012410B4 (de) 2015-09-24 2021-10-07 Dräger Safety AG & Co. KGaA Verfahren zur Herstellung eines Atemschutzfilter aus starrem Aktivkohlematerial und Atemschutzfilter aus starrem Aktivkohlematerial
KR20200129705A (ko) * 2019-05-09 2020-11-18 보령제약 주식회사 무정형의 pi3k 저해제 및 이를 포함하는 약학적 조성물
KR20200129704A (ko) * 2019-05-09 2020-11-18 보령제약 주식회사 Pi3k 저해제의 결정다형 및 이의 제조방법
CN111239125A (zh) * 2020-03-06 2020-06-05 中国药科大学 一种利用二硫化铂的葡萄糖比色检测法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5270353B2 (ja) * 2005-10-07 2013-08-21 エクセリクシス， インク． ホスファチジルイノシトール３−キナーゼインヒビターとその使用方法
WO2012065057A2 (en) * 2010-11-12 2012-05-18 Exelixis, Inc. Phosphatidylinositol 3-kinase inhibitors and methods of their use
BR112014010492A2 (pt) * 2011-11-01 2017-04-25 Exelixis Inc n-(3-{[(3-{[2-cloro-5-(metóxi)fenil]amino}quinoxalin-2-il)amino]sulfonil}fenil)-2-metilalaninamida como inibidor de fosfatidilinositol 3-cinase para o tratamento de malignidades linfoproliferativas
FR3008620A1 (fr) * 2013-07-22 2015-01-23 Sanofi Sa Formulation de comprime d'un inhibiteur de phosphatidylinositol 3-kinase

Also Published As

Publication number Publication date
CA2884337A1 (en) 2014-03-20
IL237458A0 (en) 2015-04-30
JP2015528482A (ja) 2015-09-28
SG11201501540VA (en) 2015-03-30
TW201422594A (zh) 2014-06-16
US9388143B2 (en) 2016-07-12
MX2015003151A (es) 2015-07-14
WO2014041144A1 (en) 2014-03-20
AU2013314292A1 (en) 2015-04-02
AR092501A1 (es) 2015-04-22
US20150183752A1 (en) 2015-07-02
CN104781241A (zh) 2015-07-15
RU2015113277A (ru) 2016-11-10
BR112015004901A2 (pt) 2017-07-04
EP2895467A1 (en) 2015-07-22
KR20150056565A (ko) 2015-05-26

Similar Documents

Publication Publication Date Title
UY35032A (es) Compuestos cristalinos
EA201792039A1 (ru) Гетероциклические амины в качестве ингибиторов киназы
EA201892128A1 (ru) Гетероциклические амиды, полезные в качестве модуляторов
DK3514230T3 (da) Serinproteaser af bacillus-arter
ECSP14013251A (es) Derivados de 5-flúor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona
DK3080263T3 (da) Serinproteaser af bacillus gibsonii-clade
DK3119884T3 (da) Serinproteaser af bacillus-arter
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
UA113861C2 (xx) 5-фенілзаміщені аміди n-(тетразол-5-iл)арилкарбонової кислоти і n-(триазол-5-іл)арилкарбонової кислоти і їх застосування як гербіцидів
UY33883A (es) Novedosos derivados heterocíclicos
EA201300887A1 (ru) Модуляторы s1p
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
DK3486234T3 (da) Aryl- eller heteroaryl-substituerede benzenforbindelser
EA201490450A1 (ru) Новые ингибиторы ферментов
UY34219A (es) Compuestos de 2-(2,4,5-anilino sustituido)pirimidina
EA201492210A1 (ru) Соединения, ингибирующие активность катехол-o-метилтрансферазы
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
EA201590295A1 (ru) Atx-модулирующие агенты
UY34836A (es) Nuevo organismos
EA201400838A1 (ru) ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
EA201270149A1 (ru) Ингибиторы bace
EA201391540A1 (ru) Агонисты fgfr1 и способы их применения
EA201400338A1 (ru) Производные аминопиримидина для применения в качестве модуляторов киназной активности
CL2012003358A1 (es) Compuestos derivados de n-((het) arilalquil)) pirazol (tio) carboxamidas; composicion fungicida; metodo para controlar los hongos fitopatógenos de los cultivos.
UY34654A (es) Inhibidores de la beta-secretasa

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220124